A rabbit model for evaluation of catheter-associated fungal biofilms

Jyotsna Chandra1, Lisa Long, Mahmoud A Ghannoum

  • 1Center for Medical Mycology and Department of Dermatology, University Hospitals Case Medical Center and Case Western Reserve University, Cleveland, OH, USA.

Virulence
|September 17, 2011
PubMed

Insights

This study presents a rabbit model for studying fungal biofilm infections on catheters. This model helps evaluate antifungal treatments and compare different fungal strains in vivo.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Biomaterials Science

Background:

  • Catheter-related bloodstream infections (CRBSIs) often stem from microbial biofilms on catheter surfaces.
  • Existing in vitro methods for studying fungal biofilms lack comprehensive in vivo validation.
  • There is a need for robust in vivo models to accurately assess biofilm-associated infections and treatments.

Purpose of the Study:

  • To describe a clinically relevant rabbit model for Candida albicans biofilm-associated catheter infections.
  • To provide a reproducible method for evaluating fungal biofilm morphology, topography, and architecture in vivo.
  • To establish a model for testing antifungal lock therapies and comparing fungal strains or biomaterials.

Main Methods:

  • Development and utilization of a rabbit model for catheter implantation and C. albicans inoculation.
  • In vivo biofilm formation assessment on catheter surfaces.
  • Analysis of biofilm morphology using scanning electron microscopy (SEM).
  • Quantification of fungal burden via quantitative catheter culture (QCC).

Main Results:

  • The rabbit model successfully established C. albicans biofilms on implanted catheters.
  • SEM and QCC provided detailed insights into biofilm architecture and fungal load in vivo.
  • The model allowed for the evaluation of antimicrobial lock therapy efficacy against catheter biofilms.

Conclusions:

  • The described rabbit model offers a valuable in vivo platform for studying fungal biofilm-associated catheter infections.
  • This model facilitates the assessment of antifungal efficacy, comparison of fungal strains, and testing of novel biomaterials.
  • The protocol is adaptable for typical laboratory settings and can be completed within approximately 20-25 days.

Related Concept Videos